(Q33977939)

30 July 2017

title

Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing (English)

1 reference

30 July 2017

0 references

1 reference

J Lipman

1

1 reference

30 July 2017

S C Wallis

series ordinal

2

1 reference

30 July 2017

C Rickard

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

43

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

2559-2561

1 reference

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Changes in vancomycin pharmacokinetics in critically ill infants

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Plasma protein binding and pharmacological response

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Cefepime: the next generation?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

APACHE II: a severity of disease classification system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Pharmacokinetics of antibiotics in critically ill patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Intermittent bolus dosing of ceftazidime in critically ill patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89521

Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa

29 October 2018

1 reference

12 December 2020

Subtleties of antibiotic dosages--do doses and intervals make a difference in the critically ill?

1 reference

12 December 2020

High-performance liquid chromatographic assay for cefepime in serum

1 reference

12 December 2020

The pharmacodynamics of beta-lactams

1 reference

12 December 2020

Continuous infusion ceftazidime in intensive care: a randomized controlled trial

1 reference

12 December 2020

Kinetics of antimicrobial activity

1 reference

12 December 2020

Influence of protein binding and severity of illness on renal elimination of four cephalosporin drugs in intensive-care patients

1 reference

12 December 2020

In-vitro activity of cefepime against bacterial pathogens from hospitalized patients

1 reference

12 December 2020

Pharmacokinetics of cefepime in patients with the sepsis syndrome

1 reference

12 December 2020

Generalized vascular permeability and pulmonary function in patients following serious trauma

1 reference

12 December 2020

Identifiers

PMC publication ID

89521

1 reference

30 July 2017

1 reference